20/20 Biolabs, Inc. (AIDX)
0.1869
-0.04
(-18.35%)
USD |
NASDAQ |
Nov 05, 16:00
20/20 Biolabs Enterprise Value : -0.1454M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | -0.1454M |
| November 04, 2026 | 0.3692M |
| November 03, 2026 | 0.4427M |
| November 02, 2026 | 0.4439M |
| October 30, 2026 | 0.1744M |
| October 29, 2026 | 0.3643M |
| October 28, 2026 | 0.6032M |
| October 27, 2026 | 0.4023M |
| October 26, 2026 | 0.4133M |
| October 23, 2026 | 0.4464M |
| October 22, 2026 | 0.6363M |
| October 21, 2026 | 0.8752M |
| October 20, 2026 | 0.8115M |
| October 19, 2026 | 0.7539M |
| October 16, 2026 | 0.7576M |
| October 15, 2026 | 0.9352M |
| October 14, 2026 | 1.401M |
| October 13, 2026 | 1.869M |
| October 12, 2026 | 2.049M |
| October 09, 2026 | 2.159M |
| October 08, 2026 | 2.208M |
| October 07, 2026 | 1.773M |
| October 06, 2026 | 1.883M |
| October 05, 2026 | 1.882M |
| October 02, 2026 | 2.220M |
| Date | Value |
|---|---|
| October 01, 2026 | 2.574M |
| September 30, 2026 | 2.912M |
| September 29, 2026 | 2.577M |
| September 28, 2026 | 2.576M |
| September 25, 2026 | 2.890M |
| September 24, 2026 | 2.748M |
| September 23, 2026 | 2.791M |
| September 22, 2026 | 3.329M |
| September 21, 2026 | 3.322M |
| September 18, 2026 | 3.263M |
| September 17, 2026 | 3.341M |
| September 16, 2026 | 3.455M |
| September 15, 2026 | 3.394M |
| September 14, 2026 | 3.942M |
| September 11, 2026 | 4.426M |
| September 10, 2026 | 4.185M |
| September 09, 2026 | 4.482M |
| September 08, 2026 | 4.645M |
| September 04, 2026 | 4.812M |
| September 03, 2026 | 5.056M |
| September 02, 2026 | 5.288M |
| September 01, 2026 | 5.106M |
| August 31, 2026 | 5.114M |
| August 28, 2026 | 5.210M |
| August 27, 2026 | 5.157M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sanara MedTech, Inc. | 323.70M |
| Intelligent Bio Solutions, Inc. | 2.721M |
| Anteris Technologies Global Corp. | 289.77M |
| Quest Diagnostics, Inc. | 33.91B |
| Labcorp Holdings, Inc. | 36.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.506M |
| Revenue (Quarterly) | 0.7306M |
| Total Expenses (Quarterly) | 2.237M |
| EPS Diluted (Quarterly) | -0.2247 |
| Gross Profit Margin (Quarterly) | 41.71% |
| Profit Margin (Quarterly) | -206.2% |
| Earnings Yield | -386.8% |